Invicta Diagnostic Limited (NSE: INVICTA) is a Mumbai, Maharashtra-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹94 Cr, it ranks #3,301 by market cap among the 6,197 Indian listed companies on FinBizNet, and #11 of 18 in Medical Diagnostic Centres.
| Market Cap | ₹94 Cr |
|---|---|
| NSE Symbol | INVICTA |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| Return on Equity | 9.76% |
| Return on Assets | 11.05% |
| 52-Week Range | ₹67.00 – ₹68.00 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.pcdiagnostics.in |
Promoters held 66.70% of Invicta Diagnostic Limited's shares as of Mar 2026, unchanged from Dec 2025.
Invicta Diagnostic Limited owns and operates diagnostic centers under the PC Diagnostics brand name in India. It provides pathology and radiology testing services, such as imaging, pathology/clinical laboratory, and tele-radiology; cytogenetics and high-end molecular diagnostic tests; X-rays and ultrasounds; and computerized tomography (CT), magnetic resonance imaging, and positron emission tomography CT scans. The company also offers value-added services, including home collection of specimens and house calls, and various delivery or access modes for tests reports. It caters individual and institutional customers. The company was founded in 2016 and is based in Mumbai, India.
1. Healthcare Facilities & Services-This segment owns and operates diagnostic centers under the PC Diagnostics brand name. 2. NA-NA 3. NA-NA 4. NA-NA
1. Providing Diagnostic Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Dr. Lal Pathlabs Ltd | ₹33,934 Cr | 66.4 | 21.48% | ₹874 Cr | +28.7% |
| Vijaya Diagnostic Centre Limited | ₹14,665 Cr | 84.3 | 19.70% | ₹255 Cr | +38.5% |
| Metropolis Healthcare Limited | ₹11,952 Cr | 61.5 | 13.37% | ₹497 Cr | +14.9% |
| Throcare Technologies Ltd | ₹7,764 Cr | 47.6 | 28.74% | ₹271 Cr | +7.5% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,856 Cr | 55.4 | 13.84% | ₹99 Cr | +6.9% |
| Krsnaa Diagnostics Ltd | ₹1,625 Cr | 16.8 | 10.89% | ₹271 Cr | -27.0% |
| Gaudium IVF and Women Health Limited | ₹803 Cr | 27.4 | 16.08% | ₹37 Cr | — |
| Chandan Healthcare Limited | ₹582 Cr | 21.9 | 18.43% | ₹81 Cr | — |
| Invicta Diagnostic Limited | ₹94 Cr | — | 9.76% | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Invicta Diagnostic Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Invicta Diagnostic Limited has a return on equity of 9.76%.
Invicta Diagnostic Limited is listed on the NSE under the symbol INVICTA.
Promoters held 66.70% of Invicta Diagnostic Limited's shares as of Mar 2026, unchanged from Dec 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.